Maureen A. Lefton-Greif

Maureen A. Lefton-Greif

Auto-generated profile, based on publicly available information

Maureen A. Lefton-Greif

Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2016 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
CRCynthia Rothblum-Oviatt
Cynthia Rothblum-Oviatt
JWJennifer Wright
Jennifer Wright
MLMaureen A. Lefton-Greif
Maureen A. Lefton-Greif
SMSharon A. McGrath-Morrow
Sharon A. McGrath-Morrow
TCThomas O. Crawford
Thomas O. Crawford
HLHoward M. Lederman
Howard M. Lederman
Ataxia telangiectasia (A-T) is an autosomal recessive disorder primarily characterized by cerebellar degeneration, telangiectasia, immunodeficiency, cancer susceptibility and radiation sensitivity. A-T is often referred to as a genome instability or DNA damage response syndrome. The world-wide prevalence of A-T is estimated to be between 1 in 40,000 and 1 in 100,000 live births. A-T is a complex disorder with substantial variability in the severity of features between affected individuals, and at different ages. Neurological symptoms most often first appear in early childhood when children begin to sit or walk. They have immunological abnormalities including immunoglobulin and antibody deficiencies and lymphopenia. People with A-T have an increased predisposition for cancers, particularly of lymphoid origin. Pulmonary disease and problems with feeding, swallowing and nutrition are common, and there also may be dermatological and endocrine manifestations. A-T is caused by mutations in the ATM (Ataxia Telangiectasia, Mutated) gene which encodes a protein of the same name. The primary role of the ATM protein is coordination of cellular signaling pathways in response to DNA double strand breaks, oxidative stress and other genotoxic stress. The diagnosis of A-T is usually suspected by the combination of neurologic clinical features (ataxia, abnormal control of eye movement, and postural instability) with one or more of the following which may vary in their appearance: telangiectasia, frequent sinopulmonary infections and specific laboratory abnormalities (e.g. IgA deficiency, lymphopenia especially affecting T lymphocytes and increased alpha-fetoprotein levels). Because certain neurological features may arise later, a diagnosis of A-T should be carefully considered for any ataxic child with an otherwise elusive diagnosis. A diagnosis of A-T can be confirmed by the finding of an absence or deficiency of the ATM protein or its kinase activity in cultured cell lines, and/or identification of the pathological mutations in the ATM gene. There are several other neurologic and rare disorders that physicians must consider when diagnosing A-T and that can be confused with A-T. Differentiation of these various disorders is often possible with clinical features and selected laboratory tests, including gene sequencing. Antenatal diagnosis can be performed if the pathological ATM mutations in that family have been identified in an affected child. In the absence of identifying mutations, antenatal diagnosis can be made by haplotype analysis if an unambiguous diagnosis of the affected child has been made through clinical and laboratory findings and/or ATM protein analysis. Genetic counseling can help family members of a patient with A-T understand when genetic testing for A-T is feasible, and how the test results should be interpreted. Treatment of the neurologic problems associated with A-T is symptomatic and supportive, as there are no treatments known to slow or stop the neurodegeneration. However, other manifestations of A-T, e.g. immunodeficiency, pulmonary disease, failure to thrive and diabetes can be treated effectively.

23 July 2007 in Seminars in Speech and Language
Verified
Journal Article
Closed access
PDF file
MLMaureen A. Lefton-Greif
Maureen A. Lefton-Greif
JAJoan C. Arvedson
Joan C. Arvedson
Over the past two decades, the definition of the state of health has been expanded from a disease-based condition to one that includes the impact of the disease on an individual's ability to function. The World Health Organization identified the International Classification of Functioning, Disability, and Health (ICF) as a potential framework for coding functional status and establishing a common, standardized language to describe and study health and health-related domains. The ICF could have significant benefits for speech-language pathologists working with children with feeding and swallowing problems. In this article, the authors describe the changes in the definition of health and justification for the ICF, review population trends relevant to pediatric feeding and swallowing disorders, and summarize potential applications of the ICF.

27 August 2014 in Dysphagia
Verified
Journal Article
Closed access
PDF file
MLMaureen A. Lefton-Greif
Maureen A. Lefton-Greif
SOSande O. Okelo
Sande O. Okelo
JWJennifer M. Wright
Jennifer M. Wright
JCJoseph M. Collaco
Joseph M. Collaco
SMSharon A. McGrath-Morrow
Sharon A. McGrath-Morrow
MEMichelle N. Eakin
Michelle N. Eakin

26 July 2006 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MLMaureen A. Lefton‐Greif
Maureen A. Lefton‐Greif
JCJohn L. Carroll
John L. Carroll
GLGerald M. Loughlin
Gerald M. Loughlin

21 March 2017 in Seminars in Speech and Language
Verified
Journal Article
Closed access
PDF file
JAJoan C. Arvedson
Joan C. Arvedson
MLMaureen A. Lefton-Greif
Maureen A. Lefton-Greif
Speech-language pathologists (SLPs) have fulfilled primary roles in the evaluation and management of children with feeding/swallowing disorders for more than five decades. The increased incidence and prevalence of newborns, infants, and children with feeding and swallowing disorders has resulted in increased use of instrumental swallowing evaluations. The videofluoroscopic swallow study and fiberoptic endoscopic evaluation of swallowing are the two most commonly used swallowing assessments by SLPs, with ultrasound used less frequently. This article focuses on updates over the past decade in the procedures and utility of instrumental assessments of swallowing function, and identifies future directions that may enable us to meet the needs of the children who are in our care to attain functional outcomes.

21 November 2015 in Dysphagia
Verified
Journal Article
Closed access
PDF file
SLSteven B. Leder
Steven B. Leder
JSJonathan M. Siner
Jonathan M. Siner
MBMatthew J. Bizzarro
Matthew J. Bizzarro
BMBrian M. McGinley
Brian M. McGinley
MLMaureen A. Lefton-Greif
Maureen A. Lefton-Greif